PPARalpha deficiency in inflammatory cells suppresses tumor growth.
Inflammation in the tumor bed can either promote or inhibit tumor growth. Peroxisome proliferator-activated receptor (PPAR)alpha is a central transcriptional suppressor of inflammation, and may therefore modulate tumor growth. Here we show that PPARalpha deficiency in the host leads to overt inflamm...
Main Authors: | Arja Kaipainen, Mark W Kieran, Sui Huang, Catherine Butterfield, Diane Bielenberg, Gustavo Mostoslavsky, Richard Mulligan, Judah Folkman, Dipak Panigrahy |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2007-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC1800345?pdf=render |
Similar Items
-
PPARs: A Double-Edged Sword in Cancer Therapy?
by: Dipak Panigrahy, et al.
Published: (2008-01-01) -
PPARalpha in peroxisome proliferation : molecular characterisation and species differences
by: Choudhury, Munim
Published: (2000) -
HIV-1 Tat-induced diarrhea is improved by the PPARalpha agonist, palmitoylethanolamide, by suppressing the activation of enteric glia
by: Giovanni Sarnelli, et al.
Published: (2018-03-01) -
PPARalpha-mediated effects of dietary lipids on intestinal barrier gene expression
by: Bosch-Vermeulen Hanneke, et al.
Published: (2008-05-01) -
Comparative analysis of gene regulation by the transcription factor PPARalpha between mouse and human.
by: Maryam Rakhshandehroo, et al.
Published: (2009-08-01)